The Current Ratio as of December 2024 (TTM) for Endonovo Therapeutics, Inc. (ENDV) is 0.00

According to Endonovo Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.00. This represents a change of -8.19% compared to the average of 0.00 of the last 4 quarters.

Endonovo Therapeutics, Inc. (ENDV) Historical Current Ratio (quarterly & annually)

How has ENDV Current Ratio performed in the past?

The mean historical Current Ratio of Endonovo Therapeutics, Inc. over the last ten years is 0.01. The current 0.00 Current Ratio has changed 667.19% with respect to the historical average. Over the past ten years (40 quarters), ENDV's Current Ratio was at its highest in in the September 2018 quarter at 0.04. The Current Ratio was at its lowest in in the June 2022 quarter at 0.00.

Endonovo Therapeutics, Inc. (ENDV) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Endonovo Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Endonovo Therapeutics, Inc. (ENDV) Average Current Ratio

How has ENDV Current Ratio performed in the past?

The current Current Ratio of Endonovo Therapeutics, Inc. (ENDV) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Endonovo Therapeutics, Inc. (ENDV) Current Ratio vs. Peers

How is ENDV’s Current Ratio compared to its peers?

Endonovo Therapeutics, Inc.’s Current Ratio is less than Bio-Path Holdings, Inc. (0.86), less than Cingulate Inc. (7.35), less than Purple Biotech Ltd. (1.27), less than Soleno Therapeutics, Inc. (17.26), less than Genelux Corporation (0), less than Comera Life Sciences Holdings, Inc. (6.47), less than Dyadic International, Inc. (0.90), less than Monopar Therapeutics Inc. (5.15), less than Cellectis S.A. (5.41), less than Biotron Limited (1.78), less than Bioasis Technologies Inc. (0.58), greater than Covalon Technologies Ltd. (0), less than Mosaic ImmunoEngineering Inc. (5.24), less than Quoin Pharmaceuticals, Ltd. (0.06), less than Bolt Biotherapeutics, Inc. (3.02), less than Pasithea Therapeutics Corp. (3.16), less than MediciNova, Inc. (14.81), less than Fresh Tracks Therapeutics, Inc. (16.66), less than null (6.98),

Build a custom stock screener for Endonovo Therapeutics, Inc. (ENDV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Endonovo Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Endonovo Therapeutics, Inc. (ENDV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Endonovo Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.